Agenda

17/03/2023

Human Plasma B cell characterization in autoimmunity and SARS-CoV-2 vaccination

Xipre room at 12:00h

Us convidem al pròxim IMIM Seminar organitzat pel Programa de Recerca Clínica Translacional, que tindrà lloc el divendres 17/03/2023 a les 12:00 h. El títol serà "Human Plasma B cell characterization in autoimmunity and SARS-CoV-2 vaccination", a càrrec de Pierre Bruhns, PhD, Principal Investigator. Director of Research. Unit of Antibodies in Therapy and Pathology, Dept. of Immunology, Institut Pasteur, Paris, France.

___________________________________________________________________________

We invite you to the next IMIM Seminar organized by the Translational Clinical research Program, which will take place on Friday March 17 at 12:00 h. The title will be "Human Plasma B cell characterization in autoimmunity and SARS-CoV-2 vaccination", by Pierre Bruhns, PhD, Principal Investigator. Director of Research. Unit of Antibodies in Therapy and Pathology, Dept. of Immunology, Institut Pasteur, Paris, France.

Short Bio: Pierre BRUHNS, PhD

Pr Pierre Bruhns is the Principal Investigator of the laboratory of Antibodies in Therapy and Pathology in the Department of Immunology of Institut Pasteur, Paris, France. His lab studies the role of antibodies and the cells that produce them (plasmablasts, plasma cells), the role of antibody receptors (FcR) and the cells that express them in models of disease (allergy, autoimmunity) and in therapy (vaccination and cancer immunotherapy). Pr Bruhns is an European Research Counsel grantee, and is internationally recognized for his expertise in Fc receptor biology, in vivo models and, more recently, on biological applications of droplet microfluidic technologies to antibody responses. He organized several international conferences, including 2 Keystone Symposia, 3 EMBO and 1 Gordon Research Conference. He has published >100 articles and reviews (H-index 43).

https://research.pasteur.fr/en/team/antibodies-in-therapy-and-pathology/

Pòster

Todos los actos